Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan

Atherosclerosis

Volumn 228, Issue 1, 2013, Pages 198-202

  Martino, Francesco ^a   Puddu, Paolo Emilio ^a   Pannarale, Giuseppe ^a   Colantoni, Chiara ^a   Martino, Eliana ^a   Niglio, Tarcisio ^b   Zanoni, Cristina ^a   Barillà, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Children; Cholesterol; Chromium polinicotinate; Glucomannan; Lipids; Policosanol

Indexed keywords

CHOLESTEROL; CHROMIUM DERIVATIVE; CHROMIUM POLYNICOTINATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNAN; POLICOSANOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; ATHEROSCLEROSIS; BLOOD GLUCOSE; CATHARTICS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FASTING; FATTY ALCOHOLS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MANNANS; NICOTINIC ACIDS; TRIGLYCERIDES;

EID: 84876801187     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.02.005     Document Type: Article

References (30)

1. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995, 92:1355-1374.
2. Frontini M.G., Srinivasan S.R., Xu Jihua, Tang Rong, Bond M.G., Berenson G.S. Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study. Pediatrics 2008, 121:924-929.
3. Jounala M., Viikari J.S.A., Ronnemaa T., et al. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2008, 28:1012-1017.
4. Martino F., Loffredo L., Carnevale R., et al. Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics 2008, 122:e648-e655.
5. McNeal C.J., Dajani T., Wilson D., Cassidy-Bushrow A.E., Dickerson B. Hypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease. Curr Atheroscler Rep 2010, 12:20-28.
6. Daniels S.R., Greer F.R. Lipid screening and cardiovascular health in childhood. Pediatrics 2008, 122:198-208. The Committee on Nutrition.
7. Martino F., Puddu P.E., Pannarale G., et al. Arterial blood pressure and serum lipids in a population of children and adolescents from southern Italy: the Calabrian Sierras Community Study (CSCS). Int J Cardiol 2012, 10.1016/j.ijcard.2012.11.045.
8. NCEP (National Cholesterol Educational Program For details see website. http://www.nhlbi.nih.gov/about/ncep/ncep_pd.htm.
9. AAP (American Academy of Pediatrics).Committee on Nutrition Cholesterol in childhood 2011, For details see website. http://www.aap.org/visit/cmte25.htm.
10. Haskell W.L., Spiller G.A., Jensen C.D., Ellis B.K., Gates J.E. Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am J Cardiol 1992, 69:e433-e439.
11. Jenkins D.J.A., Kendall C.W.C., Vuksan V. Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk. Am J Clin Nutr 2000, 71:e401-e402.
12. Arvill A., Bodin L. Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men. Am J Clin Nutr 1995, 61:585-659.
13. Chen H.L., Sheu W.H., Tai T.S., Liaw Y.P., Chen Y.C. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects - a randomized double-blind trial. J Am Coll Nutr 2003, 22:36-42.
14. Martino F., Martino E., Morrone F., Carnevali E., Forcone R., Niglio T. Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children. Nutr Metab Cardiovasc Dis 2005, 15:174-180.
15. Sood N., Baker W.L., Coleman C.I. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr 2008, 88:1167-1175.
16. Violi F. Introduction to nutraceuticals special issue. Cardiovasc Ther 2010, 128:185-186.
17. Vuksan V., Sievenpiper J.L., Owen R., et al. Beneficial effects of viscous dietary fiber from Konjac-Mannan in subjects with the insulin resistance syndrome. Diabetes Care 2000, 23:e9-e14.
18. Gouni-Berthold I., Berthold H.K. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 2002, 143:356-365.
19. Preuss H.G., Wallerstedt D., Talpur N., et al. Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med 2000, 31:227-246.
20. Stearns D.M., Wise J.P., Patierno S.R., Wetterhahn K.E. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 1995, 9:1643-1648.
21. Cerulli J., Grabe D.W., Gauthier I., Malone M., McGoldrick M.D. Chromium picolinate toxicity. Ann Pharmacother 1998, 32:428-431.
22. Canetti M., Moreira M., Mas R., et al. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia. Int J Clin Pharmacol Res 1995, 15:159-165.
23. Alemán C.L., Más R., Hernández C., et al. 12-month study of policosanol oral toxicity in Sprague Dawley rats. Toxicol Lett 1994, 70:77-87.
24. Brown W.H., Poon T. Introduction to organic chemistry 2005, Wiley. 3rd ed.
25. Robertson M.D., Wright J.W., Loizon E., et al. Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. J Clin Endocrinol Metab 2012, 97:3326-3332.
26. Pacifico L., Anania C., Martino F., et al. Management of metabolic syndrome in children and adolescents. Nutr Metab Cardiovasc Dis 2011, 21:455-466.
27. Davidson M.H. A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia. J Clin Lipidol 2011, 5:76-81.
28. Amundsen A.L., Ntanios F., Put N., Ose L. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur J Clin Nutr 2004, 58:1612-1620.
29. Guardamagna O., Abello F., Baracco V., Stasiowska B., Martino F. The treatment of hypercholesterolemic children: efficacy and safety of red yeast rice extract plus policosanols. Nutr Metab Cardiovasc Dis 2011, 21:424-429.
30. Carnevale R., Loffredo L., Pignatelli P., et al. Dark chocolate inhibits platelet isoprostanes via nox2 down-regulation in smokers. J Thromb Haemost 2012, 10:125-132.